US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Wacker Chemie AG (WCH) 銘柄情報

Wacker Chemie AG (WCH)

94.25

0.75

(0.80%)

終了 6月14日 5:00AM

Wacker Chemie AG (WCH) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

94.25

( 0.80% )

買値

93.75

売値

94.75

出来高

3,116

92.35 日の範囲 94.60

0.00 52 週間の範囲 0.00

時価総額

前日終値

93.50

始値

93.50

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

124,199 €

発行済株式数

49,677,983

配当利回り

PER

-6.07

1 株当たり利益 (EPS)

-16.15

歳入

5.41B

純利益

-802.8M

Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions... Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica; and binders and polymeric additives, including dispersible polymer powders and dispersions. The company also provides pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone, as well as pharmaceutical actives, food additives, and agrochemicals; and hyperpure polysilicon. In addition, it engages in forums; e-business, such as ERP system, EDI integration, delivery forecast, and e-invoicing; and support services. The company serves automotive, construction, chemical, semiconductor, consumer goods, medical technology, pharmaceutical, and photovoltaic industries. It exports its products. The company was formerly known as Wacker-Chemie GMBH and changed its name to Wacker Chemie AG in October 2005. Wacker Chemie AG was founded in 1914 and is headquartered in Munich, Germany. The company operates as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH. 詳細を表示

セクター

Materials

業界

Chemicals

ウェブサイト

www.wacker.com

本社

Munich, Germany

設立

2026

Wacker Chemie AG is listed in the Materials sector of the Tradegate (DE) with ticker WCH. The last closing price for Wacker Chemie was 93.50 €. Over the last year, Wacker Chemie shares have traded in a share price range of 0.00 € to 0.00 €.

Wacker Chemie currently has 49,677,983 shares in issue. The market capitalisation of Wacker Chemie is 4.68 € billion. Wacker Chemie has a price to earnings ratio (PE ratio) of -6.07.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

WCH - Frequently Asked Questions (FAQ)

What is the current Wacker Chemie AG share price?

The current share price of Wacker Chemie AG is 94.25 €

How many Wacker Chemie AG shares are in issue?

Wacker Chemie AG has 49,677,983 shares in issue

What is the market cap of Wacker Chemie AG?

The market capitalisation of Wacker Chemie AG is EUR 4.68B

What is the 1 year trading range for Wacker Chemie AG share price?

Wacker Chemie AG has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Wacker Chemie AG?

The price to earnings ratio of Wacker Chemie AG is -6.07

What is the cash to sales ratio of Wacker Chemie AG?

The cash to sales ratio of Wacker Chemie AG is 0.9

What is the registered address of Wacker Chemie AG?

The registered address for Wacker Chemie AG is Gisela-Stein-Strasse 1, Munich, Bavaria, 81671

What is the Wacker Chemie AG website address?

The website address for Wacker Chemie AG is www.wacker.com

Which industry sector does Wacker Chemie AG operate in?

Wacker Chemie AG operates in the Chemicals sector

EZ2

11-12-22-24. 🙏

FlashySage44

FlashySage44 29分前

The day of reckoning is coming.
Two and a half weeks until the Next ER.
8 and a half until the August one.
No buyout in sight.
When will the longs start to question the buyout not happening?
I am very interested to see what this place will be saying come September

FlashySage44

FlashySage44 48分前

You’re not wolv?

jay_tee

jay_tee 1時間前

That “yup still there” has to be the most asinine post ever. Where else would worthless paper/digital em shares be? Sure the shares are there BUT Seamus has taken its value and poured it into FOXO. He played us all well at least up to this point….safe shares sitting at .000001 is toilet paper

doogdilinger

doogdilinger 1時間前

Right place at the right time BERK buddy:

joe_techi

joe_techi 1時間前

The Rolling Stones - 2000 Light Years From Home
https://www.youtube.com/watch?v=RLhFT7YXnoI

xoom

xoom 1時間前

Exactly. Please ask your bosses to distribute shares asap..
Please ask your bosses to learn from Musk and how he treats his folks aka SpaceX shareholders.

Frankestin

Frankestin 2時間前

https://youtu.be/iH3oOVKt0WI?is=6VNcgxb-14JC0yZD

gregcod

gregcod 2時間前

Is july going to be IBATs Month?

rodeoup

rodeoup 2時間前

Spot on. This will be the best summer this company has ever had in my book!!!

Dragonman1

Dragonman1 3時間前

please send me the email

satter

satter 3時間前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 3時間前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 3時間前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 3時間前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 4時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 4時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 4時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 5時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 5時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 5時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 5時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

UBS S&P USA Dividend Ari...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。